Barclays analyst Adam Seiden reaffirmed his Outperform rating and $25 price target on Welbilt, telling investors in a research note that the company's management team appears "well prepared" to execute on the forward-thinking strategy put into place by its current executive leadership team. Seiden says Josef Matosevic, the company's incoming interim CEO, has the "clear support" of senior executives and expects him to play an "integral" role in the future of Welbilt. Seiden contends that there is still "meaningful room to run" on Welbilt's sales and margin journeys.